Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2024-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '티앤알바이오팹' covering the period from 2024.01.01 to 2024.06.30. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of private convertible bonds (제3회 무기명식 이권부 무보증 사모 전환사채). This falls under the category of company fundraising and financing activities, which corresponds to the 'Capital/Financing Update' (CAP) category.
2024-08-05 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and a subsequent correction (정정신고) to that filing. In the context of Korean corporate filings (DART), this is a regulatory disclosure regarding capital structure changes and financing. Since it details the terms of a convertible bond issuance (interest rates, conversion prices, call/put options), it falls under the 'Capital/Financing Update' category.
2024-07-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of share issuance or capital changes.
2024-07-23 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This document details the terms of the financing, including interest rates, conversion prices, put/call options, and the use of proceeds. It is a formal regulatory filing concerning capital structure and financing activities, which falls under the 'Capital/Financing Update' category.
2024-07-23 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) and a subsequent correction (정정신고) for the company TNR Biofab. It details the issuance of new shares, the purpose of the capital raise, the third-party allocation details, and the conversion terms for preferred shares. This falls under the category of announcements regarding capital changes and share issues.
2024-07-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.